Bill > SB0248

This bill amends Utah's controlled substances laws, primarily focusing on behavioral health treatment and the scheduling of certain drugs. The bill modifies the definition of "drug" and "health care provider" for behavioral health treatment programs, expanding who can develop such programs to include cancer treatment centers with palliative care providers and licensed psychiatrists with experience in clinical trials. The bill allows these providers to use drugs like psilocybin for treatment, with certain restrictions, such as only treating patients 18 and older and providing detailed reports to the Health and Human Services Interim Committee. Notably, the bill includes a provision that if the federal government reschedules the pharmaceutical composition of crystalline polymorph psilocybin to a schedule other than Schedule I, it will automatically be rescheduled in Utah accordingly. The bill also extends the repeal date for the section on drugs for behavioral health treatment from July 1, 2027, to July 1, 2029, and sets an effective date of May 7, 2025. This legislation appears to be part of a broader effort to explore alternative treatments for behavioral health conditions while maintaining careful oversight and regulation.

Health and Social Services

https://le.utah.gov/~2025/bills/static/SB0248.html